Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vitamin d Levels and Coronary Catheterization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00749541
Recruitment Status : Completed
First Posted : September 9, 2008
Last Update Posted : December 16, 2010
Sponsor:
Information provided by:
Assaf-Harofeh Medical Center

Brief Summary:

decreased vitamin d levels are associated with increased inflammatory markers,and renin angiotensin levels.

decreased levels were also found to be connected to increased cardiovascular mortality.

we therefore hypothesise that in patients with pathological results of coronary catheterization we will find decreased levels of 25 hydroxy vitamin d.

we will examine patients undergoing elective coronary catheterization and compare two groups: those with normal results and those with pathological results.


Condition or disease
Vitamin D Deficiency

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: 25 Hydroxy Vitamin d Levels in Patients Undergoing an Elective Coronary Catheterization
Study Start Date : November 2008
Actual Primary Completion Date : August 2009
Actual Study Completion Date : August 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Vitamin D
Drug Information available for: Vitamin D

Group/Cohort
1normal catheter.
abnormal catheter.



Biospecimen Retention:   Samples Without DNA
blood samples


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients undergoing an elective coronary catheterization over the age of 18.
Criteria

Inclusion Criteria:age

  • >18 years,
  • no known ihd

Exclusion Criteria:

  • renal failure ,
  • medications including vitamin d, calcium ,phosphate
  • hyper or hypoparathyroidism,
  • abnormal calcium or phosphate values,
  • known pathological coronary catheterization.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00749541


Locations
Layout table for location information
Israel
Assaf Harofeh Mc
Zerifin, Israel
Sponsors and Collaborators
Assaf-Harofeh Medical Center
Investigators
Layout table for investigator information
Principal Investigator: renana shor, md assaf harofeh mc
Layout table for additonal information
Responsible Party: dr. renana shor, assaf harofeh medical center internal medicine a
ClinicalTrials.gov Identifier: NCT00749541    
Other Study ID Numbers: vitamin d
First Posted: September 9, 2008    Key Record Dates
Last Update Posted: December 16, 2010
Last Verified: September 2008
Keywords provided by Assaf-Harofeh Medical Center:
vitamin d coronary catheterization
Additional relevant MeSH terms:
Layout table for MeSH terms
Vitamin D Deficiency
Avitaminosis
Deficiency Diseases
Malnutrition
Nutrition Disorders